Ayd, F.J. (1991). The early history of modem psychopharmacology . Neuropsychopharmacology, v, 71-84.
2.
Shorter, E. (1996). A History of Psychiatry. From the Era of the Asylum to the Age of Prozac (New York: J Wiley & Sons).
3.
Braslow, J., Mental Ills and Bodily Cures (Berkeley, CA: University of California Press, 1997).
4.
Pressman, J. (1998). The Last Resort. Psychosurgery and the Limits of Medicine (Cambridge: Cambridge University Press).
5.
Lurie, M. (1998). 'The enigma of isoniazid'. In Healy, D., The Psychopharmacologists, Vol II (London: Chapman & Hall), 119-33.
6.
Babcock-Grove, P. (ed.), Websters International Third New International Dictionary (Springfield, USA: G. & C. Merriam, 1966).
7.
Random House Dictionary of the English Language (1987). Second Edition (New York: Random House).
8.
Healy, D. (1997). The Antidepressant Era (Cambridge, MA: Harvard University Press), Chapter 7.
9.
Young, G. (1753). 'Opium in melancholia and mania'. In Hunter, R. and MacAlpine, I. (1982). Three Hundred Years of Psychiatry 1535-1860 (Hartsdale, NY: Carlisle Publishing Inc), 395-8.
10.
Woodward, S.B. (1846/1994). 'Observations on the medical treatment of insanity'. American Journal of Psychiatry, cli (6) (suppl.), 220-30.
11.
Weber, M.M. and Emrich, H.M. (1988). 'Current and historical concepts of opiate treatment in psychiatric disorders'. international Clinical Psychopharmacology, iii, 255-66.
12.
Kuhn, R. (1970). 'The discovery of imipramine'. In Ayd, F. J. and Blackwell, B. (eds), Discoveries in Biological Psychiatry ( Philadelphia, PA: Lippincott).
13.
Balme, R. (1976). 'Early medicinal uses of bromides'. Journal of the Royal College of Physicians, x, 205-8.
14.
Maudsley, H. (1895). The Pathology of Mind. Reprinted by St Martin's Press, New York, 1979 .
15.
Glatt, M.M. (1962). 'The abuse of barbiturates in the United Kingdom' . Bulletin Narcotics, xiv, 19-38.
16.
Smith, M.C. (1991). A Social History of the Minor TranquilizersNew York: Haworth Press).
17.
Lawson, R. (1876). 'A contribution to the investigation of the therapeutic actions of hyoscyamine'. Practitioner, xvii, 7-19.
18.
Hoch, P. and Mauss, W. (1932). 'Atropinbehandlung bei Geisteskrankheiten'. Arch Psychiatrie, xcvii, 546-52.
19.
Herz, A. (1965). 'Central cholinolytic activity and antidepressant effect'. In Bente, D. and Bradley, P. B., Neuropsychopharmacology, Vol. 4. Proc 4th Meeting of CINP (Amsterdam: Elsevier), 404-7.
20.
Loew, D. and Taeschler, M. (1965). 'Central anticholinergic properties of antidepressants' . In Bente, D. and Bradley, P. B., Neuropsychopharmacology, Vol. 4. Proc 4th Meeting of CINP (Amsterdam: Elsevier), 404-7.
21.
Kaspar, S., Moises, H.-W. and Beckmann, H. (1981). 'The anticholinergic biperiden in depressive disorders' . Pharmacopsychiatry, xiv, 195-8.
22.
Woodward, S.B. (1846/1994). 'Observations on the medical treatment of insanity'. American Journal of Psychiatry, cli (6) (suppl.), 220-30.
23.
Norton, A. (1979). 'Depression'. British Medical Journal, ii, 429-30.
24.
Lurie, M. (1998). 'The enigma of isoniazid'. In Healy, D., The Psychopharmacologists, Vol II (London: Chapman & Hall), 119-33.
25.
Greenberg, R.P., Bornstein, R., Greenberg, M.D. and Fisher, S. (1992). 'A meta-analysis of antidepressant outcome under "blinder" conditions'. J Consulting & Clinical Psychology, lx, 664-9.
26.
Moncrieff, J., Wessely, S. and Hardy, R. (1998). 'Meta-analysis of trials comparing antidepressants with active placebos'. British Journal of Psychiatry, clxxii, 227-31.
27.
Fisher, S. and Greenberg, R. (1979). From Placebo to Panacea (New York: John Wiley & Sons).
28.
Healy, D. (1997). The Antidepressant Era (Cambridge, MA: Harvard University Press), Chapter 1.
29.
Ibid., Chapter 2.
30.
Dub, L.M. and Lurie, L. (1939). 'Use of Benzedrine in the depressed phase of the psychotic state'. Ohio State Medical Journal, xxxv, 39-45.
31.
Chiarello, R.J. and Cole, J.O. (1987). 'The use of psychostimulants in general psychiatry'. Archives of General Psychiatry, xliv, 286-95.
32.
Healy, D. (1991). 'The marketing of 5HT: anxiety or depression' . British J Psychiatry, clviii, 737-42.
33.
Delay, J., Laine, R. and Buisson, J.-F. (1952). 'Note concernant l'action de l'isonicotinyl-hydrazide dans le traitment des états depressifs'. Annales médico-psychologiques , cx, 689-92.
34.
Salzer, H.M. and Lurie, M.L. (1953). 'Anxiety and depressive states treated with isonicotinyl hydrazide (isoniazid)'. Archives of Neurology and Psychiatry, lxx, 317-24.
35.
Thuillier, J. (1980). Les Dix Ans qui ont changé la folie (Paris).
36.
Meijer, J.W. , Meinardi, H. and Binnie, C.D. (1983). 'The development of antiepileptic drugs'. Discoveries in Pharmacology, Vol. 1, eds Parnham, M. J. and Bruinvels, J. ( Amsterdam: Elsevier), 447-80.
37.
Fischer, E. and von Mering, J. (1903). 'Über ein neue Klasse von Schlafmitteln'. Therapie der Gegenwart, xliv, 97-101.
38.
Glatt, M.M. (1962). 'The abuse of barbiturates in the United Kingdom'. Bulletin Narcotics, xiv, 19-38.
39.
Rushton, R. and Steinberg, H. (1963). 'Mutual potentiation of amphetamine and amylobarbitone measured by activity in rats'. British Journal of Pharmacology, xxi, 295-305.
40.
Christie, D. and Tansey, M. (1998). Wellcome Witness Seminar on the Introduction of the Psychotropic Drugs. Wellcome Trust , April 1997.
41.
Healy, D. (1999). 'The three faces of antidepressants. Critical comments on the clinical-economic framework of diagnosis'. J Nervous & Mental Disease, clxxxvii, 174-80
42.
Ustun, T. and Sartorius, N. (1995). Mental Illness in General Health Care (Chichester: J Wiley & Sons).
43.
Healy, D., Savage, M., Michael, P. et al. 'Psychiatric service utilisation: 1896 and 1996 compared'. Psychological Medicine (in press).
44.
Woodward, S.B. (1846/1994). 'Observations on the medical treatment of insanity'. American Journal of Psychiatry, cli (6) (suppl.), 220-30.
45.
Koppanyi, T. (1983). 'Sleep and hypnotics'. In Discoveries in Pharmacology, Vol. 1 (Amsterdam : Elsevier) 423-46.
46.
Bodoni, P. (1899) 'Dell'azione sedativa del bleu di metilene in varie forme di psicosi'. Clin Med Ital, xxxviii, 217-22.
47.
Allexsaht, W. (1938). 'The use of methylene blue in the treatment of catatonic dementia praecox patients'. Psychiatric Quarterly, xii, 245-54.
48.
Naylor, G.J. , Martin, B., Hopwood, S.E. and Watson, Y. (1986). 'A two-year double-blind crossover trial of the prophylactic effect of methylene blue in manic-depressive psychosis'. Biological Psychiatry, xxi, 915-20.
49.
Swazey, J. (1974). Chlorpromazine (Cambridge, MA: MIT Press).
50.
Healy, D. (1996). 'The rise of British psychopharmacology'. In Berrios, G. E. and Freeman, H., 150 Years of British Psychiatry, Vol. 2 (London: Athlone Press), 61-88.
51.
Cole, J.O. (1996). 'The evaluation of psychotropic drugs'. In Healy, D., The Psychopharmacologists , Vol. I (London: Chapman & Hall), 239-63.
52.
Simpson, G.E. (1998). 'Clinical psychopharmacology' . In Healy, D., The Psychopharmacologists , Vol. 2 (London: Chapman & Hall), 285-306.
53.
Johnson, F.N. (1984). The History of Lithium (Basingstoke : Macmillan Press).
54.
Lange, C. (1886). Om periodiske Depressionstilstande og deres Patagonese (Copenhagen: Jacob Lunds Forlag ).
55.
Schou, M. (1998). 'Lithium'. In The Psychopharmacologists , Vol. 2 (London: Chapman & Hall), 259-83.
56.
Hammond, W.A. (1871). A Treatise on Diseases of the Nervous System (New York: Appleton).
57.
Johnson, F.N. (1984). The History of Lithium (Basingstoke : Macmillan Press).
58.
Schou, M., Juel-Nielsen, N., Stromgren, E. and Voldby, H. (1954). 'The treatment of manic-psychoses by the administration of lithium salts'. Journal Neurol Psychiat, xvii, 250-60.
59.
Valenstein, E. (1986). Great and Desperate Cures ( New York: Basic Books).
60.
Crossley, D. (1993). 'The introduction of leucotomy: a British case history'. History of Psychiatry, iv, 553-64.
61.
Pressman, J. (1998). The Last Resort. Psychosurgery and the Limits of Medicine (Cambridge: Cambridge University Press).
62.
Braslow, J.T. (1995). 'Effect of therapeutic innovation on perception of disease and the doctor-patient relationship: a history of general paralysis of the insane and malaria fever therapy, 1910-1950' . American Journal of Psychiatry, clii, 660-5.
63.
Braslow, J.T. (1997). Mental Ills and Bodily Cures ( Berkeley, CA: University of California Press).
64.
Rees, W.I. and Healy, D. (1998). 'The place of clinical trials in the development of psychopharmacology'. History of Psychiatry, viii, 1-20.
65.
Scull, A. (1994). 'Somatic treatments and the historiography of psychiatry'. History of Psychiatry, v, 1-12.
66.
Pichot, P. (1996). 'Psychopharmacology and the history of psychiatry' . In Healy, D., The Psychopharmacologists , Vol. 1 (London: Chapman & Hall), 1-20.
67.
Fiamberti, A.M. (1950). L'Acetylcholine dans la physio-pathogenèse et dans la thérapie de la schizophrénie. Premier Congrès Mondial de Psychiatrie, Paris vol 4, 16-22.
68.
Fiamberti, A.M. (1969). 'Sul mechanismo d'azione terapeutica della "burrasca vasculore" provocate con derivati della colina' . Giornale di psychiatria e di neuropathologia, lxvii, 270-80.
69.
Janssen, P. (1998). 'From haloperidol to risperidone' . In Healy, D., The Psychopharmacologists , Vol. 2 (London: Chapman & Hall), 39-70.
70.
Rifkind, A. , Doddi, S., Karagigi, B., Borenstein, M. and Wachspress, M. (1991). 'Dosage of haloperidol for schizophrenia'. Archives of General Psychiatry, xlviii, 166-70.
71.
Van Putten, T., Marder, S.R. and Mintz, J. (1990). 'A controlled dose comparison of haloperidol in newly admitted schizophrenic patients'. Archives of General Psychiatry, xlvii, 754-8.
72.
Pedersen, V. (1998). 'Drug hunting'. In Healy, D., The Psychopharmacologists, Vol 2 (London: Chapman & Hall), 1.
73.
Healy, D., Savage, M. and Thomas, P. (in press). 'Abusive prescribing'. In Fulford, W., Health Care Ethics and Human Values.
74.
Healy, D. (1997). The Antidepressant Era (Cambridge, MA: Harvard University Press), Chapter 1.
75.
75. Ibid., Chapter 6.
76.
Lazarou, J., Pomeranz, B.H. and Corey, P.N. (1998). 'Incidence of adverse drug reactions in hospitalised patients: a meta-analysis of prospective studies'. JAMA, cclxxix, 1200-5.
77.
Scull, A. (1987). 'Desperate remedies: a Gothic tale of madness and modem medicine'. Psychological Medicine, xvii, 561-77.
78.
Kopelof, N. and Cheney, C.O. (1922). 'Studies in focal infection' . American Journal of Psychiatry, iii, 139-56.
79.
Healy, D. (1999). 'The three faces of antidepressants. Critical comments on the clinical-economic framework of diagnosis'. J. Nervous & Mental Disease, clxxxvii, 174-80.
80.
Shapiro, A. and Shapiro, E. (1998). The Powerful Placebo (Baltimore, MD: Johns Hopkins Press).
81.
Michael, P., Healy, D., Savage, M. et al. (submitted). 'Schizophrenia and related psychoses: 1896-1996' .
82.
Mulholland, M. (1998). To Comfort Always. A History of Holywell Hospital, 1898-1998 (Belfast: Homefirst Community Trust); Olsen, M.R. (1972). 'An analysis of the accumulation, discharge and characteristics of long-stay psychiatric patient population', The North Wales Hospital , Denbigh 1842-1866, MSc thesis University of Wales Bangor;Healy , D., Savage, M., Michael, P. et al. 'Psychiatric service utilisation: 1896 and 1996 compared'. Psychological Medicine (in press).
83.
Braslow, J. (1997). Mental Ills and Bodily Cures ( Berkeley, CA: University of California Press).
84.
Pressman, J. (1998). The Last Resort. Psychosurgery and the Limits of Medicine (Cambridge: Cambridge University Press, Cambridge).
85.
Scull, A. (1994). 'Somatic treatments and the historiography of psychiatry'. History of Psychiatry, v, 1-12.
86.
Shorter, E. (1996). A History of Psychiatry. From the Era of the Asylum to the Age of Prozac (New York: J. Wiley & Sons).